496 related articles for article (PubMed ID: 20398849)
1. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.
Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849
[TBL] [Abstract][Full Text] [Related]
2. Preoperative or postoperative therapy for resectable oesophageal cancer: an updated practice guideline.
Malthaner R; Wong RK; Spithoff K;
Clin Oncol (R Coll Radiol); 2010 May; 22(4):250-6. PubMed ID: 20398848
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
5. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
6. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
[TBL] [Abstract][Full Text] [Related]
7. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
8. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy in rectal cancer: stage of the disease and therapeutic approach.
Cellini N; Valentini V; Barbaro B; Marano P
Rays; 1995; 20(2):132-44. PubMed ID: 7480862
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and concurrent radiochemotherapy for rectal cancer.
Rödel C; Sauer R
Surg Oncol; 2004; 13(2-3):93-101. PubMed ID: 15572091
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiochemotherapy for rectal cancer.
Vini L
Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
[TBL] [Abstract][Full Text] [Related]
15. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data.
Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C
Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
Jonker DJ; Spithoff K; Maroun J;
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):314-22. PubMed ID: 21397476
[TBL] [Abstract][Full Text] [Related]
17. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline.
Figueredo A; Zuraw L; Wong RK; Agboola O; Rumble RB; Tandan V;
BMC Med; 2003 Nov; 1():1. PubMed ID: 14633275
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant radiochemotherapy of rectal carcinoma].
Keilholz L; Sauer R
Praxis (Bern 1994); 1995 Nov; 84(47):1377-82. PubMed ID: 7501919
[TBL] [Abstract][Full Text] [Related]
19. [Adenocarcinoma of the rectum: role of preoperative radiotherapy for the preservation of the sphincter function].
Corvò R
Recenti Prog Med; 2001 Jan; 92(1):41-4. PubMed ID: 11260969
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
